ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients
The aim of the observational study is to investigate the safety of oxcarbazepine extended release (ER) during long-term therapy in epileptic patients. In addition, quality of life parameters should be documented if assessed.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Efficacy and Safety of an ER-formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients Under Consideration of Quality of Life Parameters|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01086501
|Dr. Stephan Arnold|
|Munich, Bavaria, Germany, 80333|
|Principal Investigator:||Stephan Arnold, MD||Private Practice|